14.8557  0.019 (0.13%)		02-18 15:43
Open: 14.94 High: 15.0316 Volume: 3,438		Pre. Close: 14.8368 Low: 14.83 Market Cap: 2(M)

Short term
Mid term
Targets	6-month :	17.84	1-year :	20.84
Resists	First :	15.27	Second :	17.84
Pivot price	14.89
Supports	First :	14.68	Second :	14.31
MAs	MA(5) :	14.66	MA(20) :	14.93
	MA(100) :	15.41	MA(250) :	15.99
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	44.4	D(3) :	30.8
RSI	RSI(14): 49.8
52-week	High :	17.95	Low :	14.3

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ WDNA ] has closed above bottom band by 45.4%. Bollinger Bands are 20.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	15.03 - 15.09	15.09 - 15.13
Low:	14.68 - 14.75	14.75 - 14.81
Close:	14.74 - 14.84	14.84 - 14.92

The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.

Tue, 04 Feb 2025
WisdomTree BioRevolution Fund (BATS:WDNA) Trading 4.4% Higher – What’s Next? - Defense World

Tue, 16 Jul 2024
Biotech ETFs See Uptick Amid Positive Market Signs - Trackinsight

Mon, 01 Jul 2024
4 Up-and-Coming Small-Cap Biotech Stocks to Watch - Investing.com

Fri, 28 Jun 2024
7 Best Biotech ETFs to Buy Now - U.S News & World Report Money

Tue, 12 Dec 2023
WisdomTree launches megatrend ETF with exposure to multiple themes - The Armchair Trader

Mon, 28 Feb 2022
How Do You 'Price' Innovation? - Seeking Alpha

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: AMEX
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.